| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers
|
Pouchet, C.J.
|
|
|
20 |
4 |
p. 681-688
|
article
|
| 2 |
Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment
|
Moon, H.-G.
|
|
|
20 |
4 |
p. 636-641
|
article
|
| 3 |
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
|
Ychou, M.
|
|
|
20 |
4 |
p. 674-680
|
article
|
| 4 |
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study
|
Lissoni, A.A.
|
|
|
20 |
4 |
p. 660-665
|
article
|
| 5 |
Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development
|
Fasano, J.
|
|
|
20 |
4 |
p. 609-614
|
article
|
| 6 |
Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland
|
Spitale, A.
|
|
|
20 |
4 |
p. 628-635
|
article
|
| 7 |
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
|
Kang, Y.-K.
|
|
|
20 |
4 |
p. 666-673
|
article
|
| 8 |
CD5 expression in de novo diffuse large B-cell lymphomas
|
Went, P.
|
|
|
20 |
4 |
p. 789-790
|
article
|
| 9 |
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up
|
Kornacker, M.
|
|
|
20 |
4 |
p. 722-728
|
article
|
| 10 |
Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
|
Perotti, A.
|
|
|
20 |
4 |
p. 741-745
|
article
|
| 11 |
Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
|
Kim, H.R.
|
|
|
20 |
4 |
p. 780-787
|
article
|
| 12 |
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
|
Loriot, Y.
|
|
|
20 |
4 |
p. 703-708
|
article
|
| 13 |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow, C.-H.
|
|
|
20 |
4 |
p. 696-702
|
article
|
| 14 |
Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients
|
Shih, V.
|
|
|
20 |
4 |
p. 752-757
|
article
|
| 15 |
Editorial board
|
|
|
|
20 |
4 |
p. i-ii
|
article
|
| 16 |
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
|
Gori, S.
|
|
|
20 |
4 |
p. 648-654
|
article
|
| 17 |
ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC)
|
Witta, S.E.
|
|
|
20 |
4 |
p. 689-695
|
article
|
| 18 |
in this issue
|
|
|
|
20 |
4 |
p. 603
|
article
|
| 19 |
Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer
|
Ferrario, C.
|
|
|
20 |
4 |
p. 792-795
|
article
|
| 20 |
Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
|
Vasile, E.
|
|
|
20 |
4 |
p. 790-791
|
article
|
| 21 |
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study
|
Mustacchi, G.
|
|
|
20 |
4 |
p. 655-659
|
article
|
| 22 |
Neutropenic enterocolitis and docetaxel neoadjuvant chemotherapy
|
Dumitra, S.
|
|
|
20 |
4 |
p. 795-796
|
article
|
| 23 |
Older cancer patients in an Italian hospice
|
Cacioppo, C.
|
|
|
20 |
4 |
p. 791-792
|
article
|
| 24 |
Optimising treatment regimens for the management of advanced gastric cancer
|
Wong, R.
|
|
|
20 |
4 |
p. 605-608
|
article
|
| 25 |
Pathological characteristics of very young (≤30 years) breast cancer patients: a single-institution experience from Turkey
|
Aksoy, S.
|
|
|
20 |
4 |
p. 790
|
article
|
| 26 |
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205
|
Li, T.
|
|
|
20 |
4 |
p. 642-647
|
article
|
| 27 |
Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients’ life. Results of an Italian mortality follow-back survey
|
Costantini, M.
|
|
|
20 |
4 |
p. 729-735
|
article
|
| 28 |
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma
|
Esmaeli, B.
|
|
|
20 |
4 |
p. 709-714
|
article
|
| 29 |
Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity
|
Mir, O.
|
|
|
20 |
4 |
p. 736-740
|
article
|
| 30 |
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
|
Falandry, C.
|
|
|
20 |
4 |
p. 615-620
|
article
|
| 31 |
Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab
|
Nielsen, D.L.
|
|
|
20 |
4 |
p. 798
|
article
|
| 32 |
Survival among women with triple receptor-negative breast cancer and brain metastases
|
Dawood, S.
|
|
|
20 |
4 |
p. 621-627
|
article
|
| 33 |
Table of Contents
|
|
|
|
20 |
4 |
p. iv-vi
|
article
|
| 34 |
The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project
|
Suzumiya, J.
|
|
|
20 |
4 |
p. 715-721
|
article
|
| 35 |
The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe
|
Bosetti, C.
|
|
|
20 |
4 |
p. 767-774
|
article
|
| 36 |
The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease
|
Powles, T.
|
|
|
20 |
4 |
p. 775-779
|
article
|
| 37 |
The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong
|
Wang, X.-R.
|
|
|
20 |
4 |
p. 746-751
|
article
|
| 38 |
Trends in cancer mortality in Japanese adolescents and young adults aged 15–29 years, 1970–2006
|
Yang, L.
|
|
|
20 |
4 |
p. 758-766
|
article
|
| 39 |
Zoledronic acid-induced regression of multiple metastases at nonskeletal sites
|
Okamoto, K.
|
|
|
20 |
4 |
p. 796-797
|
article
|
Journal description